Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy?


Any good news in the race to develop a COVID-19 vaccine garners plenty of attention. That's exactly what happened last week after Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced preliminary results from a phase 1 study of COVID-19 vaccine BNT162b1.

It's not surprising that Pfizer stock jumped on the positive news. But does the potential for its COVID-19 vaccine really make the big pharma stock a buy?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments